275, Tremont St

Boston,

MA,

USA,

ZIP: 02116

Phone:

SAE Media Group is proud to announce the inaugural PFS Connect event, taking place on September 11-12, 2024, in Boston.

As a new addition to SAE's leading injectable drug delivery portfolio, PFS Connect will bring together thought leaders from big pharma, biotech, and device developers in an intimate, relaxed, and engaging setting. This event will foster collaborations and idea exchanges crucial for driving innovation in injectable drug delivery.

The two-day agenda will feature a series of roundtable discussions facilitated by industry experts sharing their invaluable expertise and experiences. These discussions will address industry challenges and emerging trends, equipping you with actionable knowledge to enhance your device development initiatives and strategic approach. Keynote presentations will provide insights into the latest case studies and innovations in the field.

We hope to welcome you to this must-attend event in September 2024! Engage in in-depth discussions with the injectable drug delivery community, helping advance device development strategies through the exchange of ideas and experiences. At PFS Connect, there are no attendees, only participants.

Gain access to 15+ roundtable discussions led by senior representatives from big pharma, biotech, and device development, discussing the industry's most pressing challenges. Hear about the latest advances and innovations in device development from those at the forefront of the industry through keynote presentations on topics such as wearable device development, incorporation of digital technologies in device lifecycle management, and more.

Take advantage of unparalleled networking opportunities, allowing you to engage and collaborate with high-level experts from big pharma and device development. These interactions will provide you with key takeaways needed to advance your device portfolio.

URL:
Brochure: https://go.evvnt.com/2445953-2?pid=1052

ADRIENNE FLETCHER - Director Packaging and Device Innovation, Johnson and Johnson Innovative Medicine, E GUAN - Head of Injection Systems, Takeda, FAWZIYA ALI - Senior Scientist, Pfizer Inc., KHAUDEJA BANO - Vice President, Combination Product Quality, Amgen, KINSUK SHAH - Sr. AD Combination Product Steward, Boehringer Ingelheim, LAWTON LAURENCE - Head of Device and Combination Product Development, Apellis, LEYA BERGQUIST - Associate Director, UserWise, MANUEL SANCHEZ-FELIX - VP Drug Delivery Search and Evaluation, Halozyme, MICHAEL SONG - Expert in aseptic filling, combination product and packaging development and commercialization,, NING YU - Executive Director, Device and Combination Product Development, Astria Therapeutics, RAM HALTHORE - Director of Engineering, Merck, RAVI KAUSHIK - Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals, RENATO RAVANELLO - Sr. Director, Device and Packaging Development, Genetech, ROBERT 'JOE' MATHER - Vice President, Head of Digital Sciences and Head of Research, Development and Regulatory, Pfizer, SARAH FAIRFIELD - Associate Director, RA Device and Combination Products Digital Device and Software, AbbVie, SHRUTI PARIKH - Director, Product Design, Takeda Pharmaceuticals, SOUMEN DAS - Medical Device Qualification Lead and Associate Scientific Fellow, Takeda Pharmaceutical Company Limited